查看购物车
  • Traditional Chinese
  • English
2021-2031年欧洲类器官市场报告：范围、细分、动态与竞争分析
市场调查报告书
商品编码
1871520

2021-2031年欧洲类器官市场报告：范围、细分、动态与竞争分析

Europe Organoids Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 233 Pages | 订单完成后即时交付

价格

欧洲类器官市场预计将大幅成长，到 2031 年将达到约 50.1603 亿美元，高于 2023 年的 10.1812 亿美元，在此期间的年复合成长率(CAGR) 为 22.1%。

执行摘要和市场分析

欧洲类器官市场分为多个区域，包括德国、法国、义大利、英国、西班牙和欧洲其他地区。该市场的成长受多种因素驱动，包括组织工程和器官移植需求的不断增长、类器官在疾病建模、基因突变研究和肿瘤建模中应用的日益广泛，以及与类器官相关的研究活动的增加。此外，来自公共和私营部门的资金和投资预计将在未来几年为市场扩张创造良好的机会。

市场区隔分析

欧洲类器官市场可以透过多种细分市场进行分析，包括类型、应用、来源、供应和方法：

  • 类型：市场依类器官来源可分为肠道、肝臟、胃、胰臟、肺、脑、肾臟等。 2023年，肠道类器官占据最大的市场份额。
  • 应用领域：类器官的应用包括发育生物学、传染病病理学、再生医学、药物毒性和疗效测试、药物发现以及个人化医疗。 2023年，发育生物学应用占据了市场主导地位。
  • 资料来源：市场分为源自多能干细胞的类器官和源自器官特异性成体干细胞的类器官，其中多能干细胞在 2023 年将占据更大的市场份额。
  • 产品/服务：此部分包括仪器、耗材和服务，其中耗材在 2023 年占据市场主导地位。仪器又分为设备和仪器，而耗材包括感测器和其他物品。
  • 方法：类器官生产所使用的方法包括微图案板、超低附着板、悬滴法、微滴法或乳液法，其中以悬滴法在 2023 年最为普遍。

市场展望

对创新药物的需求正在加速药物发现和研究的步伐。截至2021年，ClinicalTrials.gov网站上註册的临床试验研究约有384,288项。 HUB的一项调查显示，类器官可以透过识别不太可能从某些治疗中获益的患者来提高昂贵药物的成本效益，从而优化临床试验设计。类器官不仅用于癌症研究，也用于囊性纤维化、多囊性肾病变、小头畸形、肠道和呼吸道感染等相关疾病的研究。它们可以复製器官的特性，包括结构和功能，并能恢復组织的遗传和表观遗传状态，使其适用于基因编辑应用。

近期研究表明，将CRISPR-Cas9技术与类器官结合，有望在囊性纤维化等疾病的治疗方面取得突破性进展。例如，2020年的一项研究重点介绍了一个包含664名囊性纤维化患者肠道类器官的生物样本库，其中相当一部分类器官可能受益于基因编辑。然而，基因编辑类器官的效率和成功率仍面临挑战，需要对其安全性、稳定性和功能性进行深入研究。目前，药物研发正不断聚焦于先前未探索的医学领域，为类器官市场带来了巨大的成长机会。

国家概况

欧洲类器官市场进一步按国家分析，德国在2023年占据市场领导地位。德国以其强大的生物技术产业而闻名，该产业以高品质的产品和众多大型生物技术公司为特征。例如，位于明斯特的马克斯·普朗克分子生物医学研究所的研究人员在自动化生产中脑类器官方面取得了长足进步，增强了大规模研究和高通量药物发现的潜力。

德国对组织工程和器官移植的需求预计将推动市场成长，因为器官供需之间存在巨大缺口。 2021年，德国仅捐赠了2,905个器官，而移植等待名单上的需求量却高达8,730个。人类类器官正越来越多地被用于疾病研究，并有望成为可移植器官，从而缓解组织排斥反应和引入动物病原体的风险。

公司简介

类器官市场的主要参与者包括STEMCELL Technologies Inc.、Molecular Devices、Hubrecht Organoid Technology、Definigen、Organoid Therapeutics、Thermo Fisher Scientific、Corning、Merck KGaA、InSphero、ACRO Biosystems、Bio-Techne、SUN bioscience、ORGANOID SCIS、Parto） Biologics、3Dnamics和Cellesce。这些公司正透过扩张、产品创新以及併购等多种策略来增强市场份额并提供创新解决方案。

目录

第一章：引言

第二章：执行概要

  • 关键见解

第三章：研究方法

  • 二手研究
  • 初步研究
    • 假设的提出：
    • 宏观经济因素分析：
    • 发展基础数字：
    • 数据三角测量：
    • 国家层面资料：

第四章：欧洲类器官市场－主要市场动态

  • 市场驱动因素
    • 对肿瘤建模和生物样本库的需求日益增长
    • 个人化药物的广泛应用
  • 市场限制
    • 缺乏熟练的专业人才
  • 市场机会
    • 重点关注药物发现活动
  • 未来趋势
    • 类器官与晶片器官的结合
  • 驾驶员和安全带的影响：

第五章：类器官市场－欧洲分析

  • 2021-2031年欧洲类器官市场收入
  • 欧洲类器官市场预测分析

第六章：欧洲类器官市场分析－依类型

  • 肠
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第七章：欧洲类器官市场分析－按应用领域划分

  • 发育生物学疾病
  • 传染病病理学
  • 再生医学
  • 药物毒性和疗效测试
  • 药物发现与个人化医疗
  • 其他的

第八章：欧洲类器官市场分析－依来源划分

  • 多能干细胞
  • 器官特异性成体干细胞

第九章：欧洲类器官市场分析－依产品/服务分类

  • 仪器
  • 消耗品
  • 服务

第十章：欧洲类器官市场分析－依方法划分

  • 微图案板
  • 超低附件板
  • 悬垂
  • 微滴或乳液
  • 其他的

第十一章：欧洲类器官市场—国家分析

  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第十二章：行业概况

  • 概述
  • 类器官市场成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十三章：公司简介

  • STEMCELL Technologies Inc
  • Molecular Devices, LLC.
  • Hubrecht Organoid Technology
  • Definigen
  • Organoid Therapeutics
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero
  • ACRO Biosystems.
  • Bio-Techne Corp
  • SUN bioscience SA
  • ORGANOID SCIENCES Co., Ltd.
  • Crown Bioscience Inc
  • Sartorius AG
  • 3D Biotek LLC
  • Prellis Biologics Inc.
  • 3Dnamics Inc.
  • Cellesce Ltd

第十四章：附录

Product Code: TIPRE00018856

The Europe organoids market is projected to grow significantly, reaching approximately US$ 5,016.03 million by 2031, up from US$ 1,018.12 million in 2023, reflecting a compound annual growth rate (CAGR) of 22.1% during this period.

Executive Summary and Market Analysis

The organoids market in Europe is divided into several regions, including Germany, France, Italy, the UK, Spain, and the Rest of Europe. The growth of this market is driven by several factors, including the increasing demand for tissue engineering and organ transplantation, the rising use of organoids in disease modeling, gene mutation studies, and tumor modeling, as well as heightened research activities related to organoids. Additionally, the influx of funding and investments from both public and private sectors is expected to create promising opportunities for market expansion in the coming years.

Market Segmentation Analysis

The Europe organoids market can be analyzed through various segments, including type, application, source, offering, and method:

  • Type: The market is categorized into organoids derived from the intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2023, the intestine organoids held the largest market share.
  • Application: The applications of organoids include developmental biology, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery, and personalized medicine. Developmental biology applications dominated the market in 2023.
  • Source: The market is divided into organoids sourced from pluripotent stem cells and organ-specific adult stem cells, with pluripotent stem cells holding a larger market share in 2023.
  • Offering: This segment includes instruments, consumables, and services, with consumables leading the market in 2023. Instruments are further divided into devices and equipment, while consumables include sensors and other items.
  • Method: The methods used in organoid production include micropatterned plates, ultralow attachment plates, hanging drop, microdroplet or emulsion techniques, with the hanging drop method being the most prevalent in 2023.

Market Outlook

The demand for innovative drugs is accelerating the pace of drug discovery and research. As of 2021, there were approximately 384,288 clinical trial studies registered on ClinicalTrials.gov. A survey by HUB indicates that organoids can enhance the cost-effectiveness of expensive drugs by identifying patients unlikely to benefit from certain treatments, thus optimizing clinical trial designs. Organoids are not only utilized in cancer research but also in studies related to cystic fibrosis, polycystic kidney disease, microcephaly, and infections affecting the gut and airways. They can replicate organ properties, including structure and function, and can restore the genetic and epigenetic states of tissues, making them suitable for gene editing applications.

Recent studies have shown promising results in combining CRISPR-Cas9 technology with organoids, leading to advancements in treatments for conditions like cystic fibrosis. For example, a 2020 study highlighted a biobank of cystic fibrosis intestinal organoids from 664 patients, with a significant portion potentially benefiting from gene editing. However, challenges remain regarding the efficiency and success rates of gene-edited organoids, necessitating further research into their safety, stability, and functionality. The ongoing focus on drug discovery in previously unexplored medical areas presents substantial growth opportunities for the organoids market.

Country Insights

The Europe organoids market is further analyzed by country, with Germany leading the market in 2023. Germany is recognized for its robust biotechnology sector, characterized by high-quality products and the presence of major biotechnology firms. For instance, researchers at the Max Planck Institute for Molecular Biomedicine in Munster have made strides in automating the production of midbrain organoids, enhancing the potential for large-scale research and high-throughput drug discovery.

The demand for tissue engineering and organ transplantation in Germany is expected to drive market growth, as there is a significant gap between organ supply and demand. In 2021, only 2,905 organs were donated, while the demand on the transplant list reached 8,730. Human organoids are increasingly being used to study diseases and have the potential to serve as transplantable organs, mitigating issues related to tissue rejection and the risk of introducing animal pathogens.

Company Profiles

Key players in the organoids market include STEMCELL Technologies Inc., Molecular Devices, Hubrecht Organoid Technology, Definigen, Organoid Therapeutics, Thermo Fisher Scientific, Corning, Merck KGaA, InSphero, ACRO Biosystems, Bio-Techne, SUN bioscience, ORGANOID SCIENCES, Crown Bioscience, Sartorius AG, 3D Biotek, Prellis Biologics, 3Dnamics, and Cellesce. These companies are pursuing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Organoids Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 4.1.2 Surging Adoption of Personalized Drugs
  • 4.2 Market Restraints
    • 4.2.1 Dearth of Skilled Professionals
  • 4.3 Market Opportunities
    • 4.3.1 Focus on Drug Discovery Activities
  • 4.4 Future Trends
    • 4.4.1 Combination of Organoids and Organ-on-a-Chip
  • 4.5 Impact of Drivers and Restraints:

5. Organoids Market - Europe Analysis

  • 5.1 Europe Organoids Market Revenue (US$ Million), 2021-2031
  • 5.2 Europe Organoids Market Forecast Analysis

6. Europe Organoids Market Analysis - by Type

  • 6.1 Intestine
    • 6.1.1 Overview
    • 6.1.2 Intestine: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Liver
    • 6.2.1 Overview
    • 6.2.2 Liver: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Stomach
    • 6.3.1 Overview
    • 6.3.2 Stomach: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Pancreas
    • 6.4.1 Overview
    • 6.4.2 Pancreas: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Lung
    • 6.5.1 Overview
    • 6.5.2 Lung: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.6 Brain
    • 6.6.1 Overview
    • 6.6.2 Brain: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.7 Kidney
    • 6.7.1 Overview
    • 6.7.2 Kidney: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Europe Organoids Market Analysis - by Application

  • 7.1 Developmental Biology Disease
    • 7.1.1 Overview
    • 7.1.2 Developmental Biology Disease: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Pathology of Infectious Disease
    • 7.2.1 Overview
    • 7.2.2 Pathology of Infectious Disease: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Regenerative Medicine
    • 7.3.1 Overview
    • 7.3.2 Regenerative Medicine: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Drug Toxicity and Efficacy Testing
    • 7.4.1 Overview
    • 7.4.2 Drug Toxicity and Efficacy Testing: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Drug Discovery and Personalized Medicine
    • 7.5.1 Overview
    • 7.5.2 Drug Discovery and Personalized Medicine: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Organoids Market Analysis - by Source

  • 8.1 Pluripotent Stem Cells
    • 8.1.1 Overview
    • 8.1.2 Pluripotent Stem Cells: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Organ-Specific Adult Stem Cell
    • 8.2.1 Overview
    • 8.2.2 Organ-Specific Adult Stem Cell: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Organoids Market Analysis - by Offering

  • 9.1 Instruments
    • 9.1.1 Overview
    • 9.1.2 Instruments: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Consumables
    • 9.2.1 Overview
    • 9.2.2 Consumables: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Services
    • 9.3.1 Overview
    • 9.3.2 Services: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Organoids Market Analysis - by Method

  • 10.1 Micropatterned Plates
    • 10.1.1 Overview
    • 10.1.2 Micropatterned Plates: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.2 Ultralow Attachment Plates
    • 10.2.1 Overview
    • 10.2.2 Ultralow Attachment Plates: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.3 Hanging Drop
    • 10.3.1 Overview
    • 10.3.2 Hanging Drop: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.4 Microdroplet or Emulsion
    • 10.4.1 Overview
    • 10.4.2 Microdroplet or Emulsion: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. Europe Organoids Market - Country Analysis

  • 11.1 Europe
    • 11.1.1 Europe Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 Europe Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.2 Germany: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.2.1 Germany: Europe Organoids Market Share - by Type
        • 11.1.1.2.2 Germany: Europe Organoids Market Share - by Application
        • 11.1.1.2.3 Germany: Europe Organoids Market Share - by Source
        • 11.1.1.2.4 Germany: Europe Organoids Market Share - by Offering
        • 11.1.1.2.5 Germany: Europe Organoids Market Share - by Instruments
        • 11.1.1.2.6 Germany: Europe Organoids Market Share - by Consumables
        • 11.1.1.2.7 Germany: Europe Organoids Market Share - by Method
      • 11.1.1.3 France: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.3.1 France: Europe Organoids Market Share - by Type
        • 11.1.1.3.2 France: Europe Organoids Market Share - by Application
        • 11.1.1.3.3 France: Europe Organoids Market Share - by Source
        • 11.1.1.3.4 France: Europe Organoids Market Share - by Offering
        • 11.1.1.3.5 France: Europe Organoids Market Share - by Instruments
        • 11.1.1.3.6 France: Europe Organoids Market Share - by Consumables
        • 11.1.1.3.7 France: Europe Organoids Market Share - by Method
      • 11.1.1.4 United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.4.1 United Kingdom: Europe Organoids Market Share - by Type
        • 11.1.1.4.2 United Kingdom: Europe Organoids Market Share - by Application
        • 11.1.1.4.3 United Kingdom: Europe Organoids Market Share - by Source
        • 11.1.1.4.4 United Kingdom: Europe Organoids Market Share - by Offering
        • 11.1.1.4.5 United Kingdom: Europe Organoids Market Share - by Instruments
        • 11.1.1.4.6 United Kingdom: Europe Organoids Market Share - by Consumables
        • 11.1.1.4.7 United Kingdom: Europe Organoids Market Share - by Method
      • 11.1.1.5 Italy: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.5.1 Italy: Europe Organoids Market Share - by Type
        • 11.1.1.5.2 Italy: Europe Organoids Market Share - by Application
        • 11.1.1.5.3 Italy: Europe Organoids Market Share - by Source
        • 11.1.1.5.4 Italy: Europe Organoids Market Share - by Offering
        • 11.1.1.5.5 Italy: Europe Organoids Market Share - by Instruments
        • 11.1.1.5.6 Italy: Europe Organoids Market Share - by Consumables
        • 11.1.1.5.7 Italy: Europe Organoids Market Share - by Method
      • 11.1.1.6 Spain: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.6.1 Spain: Europe Organoids Market Share - by Type
        • 11.1.1.6.2 Spain: Europe Organoids Market Share - by Application
        • 11.1.1.6.3 Spain: Europe Organoids Market Share - by Source
        • 11.1.1.6.4 Spain: Europe Organoids Market Share - by Offering
        • 11.1.1.6.5 Spain: Europe Organoids Market Share - by Instruments
        • 11.1.1.6.6 Spain: Europe Organoids Market Share - by Consumables
        • 11.1.1.6.7 Spain: Europe Organoids Market Share - by Method
      • 11.1.1.7 Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.7.1 Rest of Europe: Europe Organoids Market Share - by Type
        • 11.1.1.7.2 Rest of Europe: Europe Organoids Market Share - by Application
        • 11.1.1.7.3 Rest of Europe: Europe Organoids Market Share - by Source
        • 11.1.1.7.4 Rest of Europe: Europe Organoids Market Share - by Offering
        • 11.1.1.7.5 Rest of Europe: Europe Organoids Market Share - by Instruments
        • 11.1.1.7.6 Rest of Europe: Europe Organoids Market Share - by Consumables
        • 11.1.1.7.7 Rest of Europe: Europe Organoids Market Share - by Method

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Organoids Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 STEMCELL Technologies Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Molecular Devices, LLC.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Hubrecht Organoid Technology
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Definigen
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Organoid Therapeutics
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Thermo Fisher Scientific Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Merck KGaA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 InSphero
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ACRO Biosystems.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Bio-Techne Corp
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 SUN bioscience SA
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 ORGANOID SCIENCES Co., Ltd.
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Crown Bioscience Inc
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Sartorius AG
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 3D Biotek LLC
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 Prellis Biologics Inc.
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 3Dnamics Inc.
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments
  • 13.19 Cellesce Ltd
    • 13.19.1 Key Facts
    • 13.19.2 Business Description
    • 13.19.3 Products and Services
    • 13.19.4 Financial Overview
    • 13.19.5 SWOT Analysis
    • 13.19.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners

List Of Tables

  • Table 1. Europe Organoids Market Segmentation
  • Table 2. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Offering
  • Table 7. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Method
  • Table 8. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 9. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 10. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 11. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 12. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 13. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 14. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 15. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 16. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 17. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 18. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 19. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 20. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 21. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 22. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 23. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 24. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 25. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 26. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 27. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 28. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 29. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 30. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 31. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 32. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 33. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 34. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 35. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 36. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 37. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 38. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 39. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 40. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 41. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 42. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 43. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 44. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 45. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 46. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 47. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 48. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 49. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 50. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 51. Recent Organic Growth Strategies in Organoids Market
  • Table 52. Recent Inorganic Growth Strategies in the Organoids Market

List Of Figures

  • Figure 1. Europe Organoids Market Segmentation - Country
  • Figure 2. Europe Organoids Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Organoids Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Organoids Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Liver: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Stomach: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Pancreas: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Lung: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Brain: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Kidney: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Others: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Europe Organoids Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Regenerative Medicine: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Others: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Europe Organoids Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. Organ-Specific Adult Stem Cell: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Europe Organoids Market Share (%) - by Offering (2023 and 2031)
  • Figure 25. Instruments: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Consumables: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Services: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. Europe Organoids Market Share (%) - by Method (2023 and 2031)
  • Figure 29. Micropatterned Plates: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. Ultralow Attachment Plates: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. Hanging Drop: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. Microdroplet or Emulsion: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Others: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Europe Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 35. Germany: Europe Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 36. France: Europe Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 37. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 38. Italy: Europe Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 39. Spain: Europe Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 40. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 41. Growth Strategies in Organoids Market